INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $342,000 | -16.4% | 12,000 | 0.0% | 0.08% | -29.9% |
| Q1 2021 | $409,000 | +2.5% | 12,000 | 0.0% | 0.11% | -18.3% |
| Q4 2020 | $399,000 | +3.4% | 12,000 | 0.0% | 0.13% | +50.6% |
| Q3 2020 | $386,000 | +17.0% | 12,000 | 0.0% | 0.09% | +17.6% |
| Q2 2020 | $330,000 | +71.9% | 12,000 | 0.0% | 0.07% | +105.6% |
| Q1 2020 | $192,000 | -73.2% | 12,000 | -60.0% | 0.04% | -33.3% |
| Q4 2019 | $716,000 | +35.3% | 30,000 | 0.0% | 0.05% | +63.6% |
| Q3 2019 | $529,000 | – | 30,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |